Product Details for: Pavblu

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravitreal
2MG/0.05ML
Single-Dose Vial
351(k) Biosimilar
Pavblu
Rx
002
Injection
Intravitreal
2MG/0.05ML
Pre-Filled Syringe
351(k) Biosimilar
Pavblu
Rx
Proper Name
aflibercept-ayyh
Reference Product Proper Name
aflibercept
Reference Product Properietary Name
Eylea
BLA Number
761298
Applicant
Amgen Inc.
Original Approval Date
August 23, 2024
Date of First Licensure
RETURN TO SEARCH RESULTS